Skip to main content

Table 3 Comparison between active-acupuncture and placebo-acupuncture groups in occurrence rate and severity of nausea

From: Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial

Time after TACE (days)

Patients with nausea [cases (%)]

P

Severity of nausea [cases (%)]

P

Placebo-acupuncture group

Active-acupuncture group

Placebo-acupuncture group

Acupu-ncture group

Degree 1

Degree 2

Degree 3

Degree 1

Degree 2

Degree 3

0

34 (48.6)

26 (36.1)

0.133

36 (51.4)

22 (31.4)

12 (17.1)

46 (63.9)

19 (26.4)

7 (9.7)

0.256

1

30 (42.9)

26 (36.1)

0.411

40 (57.1)

20 (28.6)

10 (14.3)

46 (63.9)

15 (20.8)

11 (15.3)

0.562

2

30 (42.9)

28 (38.9)

0.631

40 (57.1)

18 (25.7)

12 (17.1)

44 (61.1)

21 (29.2)

7 (9.7)

0.426

3

21 (30.0)

22 (30.1)

0.943

49 (70.0)

15 (21.4)

6 (8.6)

50 (69.4)

16 (22.2)

6 (8.3)

0.993

4

19 (27.1)

17 (23.6)

0.629

51 (72.9)

16 (22.9)

3 (4.3)

55 (76.4)

13 (18.1)

4 (5.6)

0.750

5

14 (20.0)

13 (18.0)

0.768

56 (80.0)

12 (17.1)

2 (2.9)

59 (81.9)

9 (12.5)

4 (5.6)

0.564

  1. Degree1: No nausea; degree 2: very mild to moderate nausea; degree 3: severe to intolerable nausea
  2. TACE transcatheter arterial chemoembolization